AbbVie (NYSE:ABBV) Shares Up 0.7% After Analyst Upgrade
AbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price shot up 0.7% on Tuesday after Guggenheim raised their price target on the stock from $214.00 to $216.00. Guggenheim currently has a buy rating on the stock. AbbVie traded as high as $194.16 and last traded at $193.70. 1,669,926 shares were traded during trading, a decline […]
AbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price shot up 0.7% on Tuesday after Guggenheim raised their price target on the stock from $214.00 to $216.00. Guggenheim currently has a buy rating on the stock. AbbVie traded as high as $194.16 and last traded at $193.70. 1,669,926 shares were traded during trading, a decline […]
